Shandong Xinhua Pharmaceutical Company Limited (XIN) — Cash Flow Quality Index
Shandong Xinhua Pharmaceutical Company Limited (XIN) has a Cash Flow Quality Index of 0.46x as of September 2023. Operating cash flow of €56.11 Million is below net income of €122.16 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore XIN cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shandong Xinhua Pharmaceutical Company Limited Cash Flow Quality Index (2013–2025)
Historical Cash Flow Quality Index for Shandong Xinhua Pharmaceutical Company Limited across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check cash flow reinvestment rate of Shandong Xinhua Pharmaceutical Company L to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Shandong Xinhua Pharmaceutical Company Limited (2013–2025)
Year-by-year earnings quality comparison for Shandong Xinhua Pharmaceutical Company Limited. For live market cap and the full company financial profile, see market value of Shandong Xinhua Pharmaceutical Company L.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.84x | €533.73 Million | €289.89 Million | ▲ +135.4% |
| 2024 | 0.78x | €367.61 Million | €470.02 Million | ▲ +46.4% |
| 2023 | 0.53x | €265.28 Million | €496.51 Million | ▼ -71.0% |
| 2022 | 1.84x | €758.24 Million | €411.19 Million | ▲ +148.0% |
| 2021 | 0.74x | €259.12 Million | €348.55 Million | ▼ -42.5% |
| 2020 | 1.29x | €420.19 Million | €324.86 Million | ▲ +11.4% |
| 2019 | 1.16x | €348.27 Million | €299.97 Million | ▼ -8.5% |
| 2018 | 1.27x | €323.91 Million | €255.31 Million | ▼ -31.8% |
| 2017 | 1.86x | €389.97 Million | €209.59 Million | ▼ -48.2% |
| 2016 | 3.59x | €439.35 Million | €122.27 Million | ▼ -14.4% |
| 2015 | 4.20x | €348.64 Million | €83.06 Million | ▼ -38.5% |
| 2014 | 6.83x | €346.34 Million | €50.73 Million | ▲ +154.6% |
| 2013 | 2.68x | €104.99 Million | €39.15 Million | — |